| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sana Biotechnology, Inc. | Acting Chief Financial Officer and Principal Accounting Officer | Common Stock | 178K | $791K | $4.44 | 04 Dec 2025 | Direct |
| Sana Biotechnology, Inc. | Acting Chief Financial Officer and Principal Accounting Officer | Restricted Stock Units | 0 | $25K | $2.56 | 03 Dec 2025 | Direct |
| Sana Biotechnology, Inc. | Acting Chief Financial Officer and Principal Accounting Officer | Stock Option (Right to Buy) | 188K | 06 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SANA | Sana Biotechnology, Inc. | 06 Mar 2025 | 5 | -$2.14K | 4 | Acting Chief Financial Officer and Principal Accounting Officer | 10 Mar 2025, 20:13 |
| SANA | Sana Biotechnology, Inc. | 02 Mar 2025 | 3 | -$1.25K | 4 | Acting Chief Financial Officer and Principal Accounting Officer | 03 Mar 2025, 19:28 |
| SANA | Sana Biotechnology, Inc. | 02 Jan 2025 | 3 | -$2.58K | 4 | Acting Chief Financial Officer and Principal Accounting Officer | 03 Jan 2025, 16:15 |
| SANA | Sana Biotechnology, Inc. | 13 Dec 2024 | 8 | -$17.3K | 4 | Acting Chief Financial Officer and Principal Accounting Officer; Exhibit List: Ex. 24 - Power of Attorney | 05 Dec 2025, 17:04 |
| SANA | Sana Biotechnology, Inc. | 04 Oct 2024 | 0 | $0 | 3 | Acting Chief Financial Officer and Principal Accounting Officer; Exhibit List: Ex. 24 - Power of Attorney | 15 Oct 2024, 18:43 |